- Email: [email protected]
Petrochina planning hydrocracking unit
FOCUS also spends €10 M annually on fuel cells. Meuse-Rhine Journal, 15 Mar 2004, (106) (Wadsworth & Wadsworth Assoc, PO Box 42, NL6245 ZG, Eijsden, The Netherlands. Tel: +31 43 4093719. Fax: +31 43 4098899. Website: http://www.webcontentnow.com)
VioQuest Pharmaceuticals expands commercial catalyst portfolio VioQuest Pharmaceuticals Inc is pleased to announce that subsidiary Chiral Quest has introduced its proprietary chiral catalyst DuanPhos for commercial-scale shipping on a kilogram scale. VioQuest, in addition to acquiring innovative oncologic, metabolic, and anti-inflammatory therapeutic compounds for unmet medical needs, offers a growing family of latest generation technology in the manufacture of optically pure therapeutics for the pharmaceutical industry. VioQuest Pharmaceuticals Inc is a drug development company focused on acquiring and bringing to market therapies for oncology, metabolic, and inflammatory diseases and disorders that are current unmet medical needs. Press release from: VioQuest Pharmaceuticals Inc, 149 West Fairmount Avenue, State College, PA 16801, USA. Tel: +1 814 234 2348. Fax: +1 814 234 2494. E-mail: [email protected]. Website: http://www.chiralquest.com (4 Apr 2005)
NEW PLANTS Criterion to re-open hydroprocessing catalyst plant Criterion Catalysts and Technologies is to re-open a mothballed hydroprocessing catalyst plant in Michigan City, IN. The market for these catalysts is growing by 45%/year, partly because of the growing need for catalysts to make low-sulfur diesel fuel.
ON
C ATA LY S T S
manufacture speciality catalysts and pharmaceutical actives ingredients and intermediates. The company’s medium term plans are for sales of Yen 10.5 bn and an ordinary profit of Yen 790 M. In the year to Mar 2005 sales will rise 3.9% to Yen 9.6 bn and ordinary profit will be unchanged at Yen 590 M. Japan Chemical Week, 31 Mar 2005, 46 (2312), 6
Petrochina planning hydrocracking unit PetroChina Co Ltd is investing $3.29 bn to expand capacity at its refining and petrochemical complex at Dushanzi, Xinjiang Province, China. It will install UOP LLC proprietary technology in a hydrocracking facility which is due onstream in 2007. The unit will process 41,000 bbl/day of gasoil to produce ethylene and diesel.
Hydrocarbon Processing, Mar 2005, 85 (3), 34
Foster Wheeler wins hydrotreater project Foster Wheeler Iberia, a wholly-owned subsidiary of Foster Wheeler, has signed a detailed engineering, equipment and material supply, and construction contract with AB Mazeikiai Nafta, for a fluid catalytic cracker gasoline selective hydrotreater unit (Axens license) at Mazeikiai refinery in northwest Lithuania. The contract value is about $43 M. The termination of the project is scheduled for 4Q 2006. The facility comprises of a 32,000 bbl/day sulfur hydrogenation unit and 22,000 bbl/day hydrodesulfurisation unit. Chemical Engineering World, Feb 2005, 40 (2), 55
Oil and Gas Journal, 14 Mar 2005, 103 (10), 10
Qatar Petroleum, Sasol Chevron sign MOU for GTL base oil project Qatar Petroleum and Sasol Chevron announce the signing of a Memorandum of Understanding for GTL Base Oils. The Memorandum of Understanding defines how the two parties intend to design, construct, and operate a Base Oils plant in Qatar as a value-add retrofit to ORYX GTL. Expected start-up is the 1H of 2008. ORYX GTL, a jv between Qatar Petroleum and Sasol, is a world first and is the largest commercial GTL plant outside South Africa. The new Base Oils plant will produce a range of high quality base oils. GTL base oils are the primary feedstock for high quality lubricants. The technology for the Base Oils project will be supplied by Chevron Texaco.
Chemical Week, 16 Mar 2005, 167 (9), 6 & European Chemical News, 21 Mar 2005, 82 (2139), 12
Press release from: Sasol, USA. Website: http://www.sasol.com (2 Mar 2005) & European Chemical News, 4 Apr 2005, 82 (2141), 23 & Chimie Pharma Hebdo, 14 Mar 2005, (291), 11 (in French)
Yuki Gosei to construct Grignard reaction plant
Haldor provides licencing and engineering to an ammonia plant
Yuki Gosei Kogyo is to invest Yen 3 bn to expand its plant at Tokwa, Japan, in a project that will, take from Apr 2005 to Apr 2007. The expansion includes a continuous Grignard reaction plant and units to
Haldor Topsoe A/S will provide licensing, engineering design, catalyst, and critical equipment supply to Ningxia Petrochemical Co’s ammonia plant revamp in the Ningxia Hui Autonomous Region. Ammonia
MAY 2005
capacity will be raised from 907,000 tonne/day to 1.5 M tonne/day. Topsoe will utilise its prereforming technology.
NEW TECHNOLOGY Peroxide-PO processes integrated DegussaHeadwaters, a jv of Degussa and the technology company Headwaters, has successfully integrated its pilot plant for synthesizing hydrogen peroxide directly from hydrogen and oxygen with a pilot plant for producing propylene oxide from hydrogen peroxide. DegussaHeadwaters expects to make the route commercially available in 2007. The companies believe they can reduce the investment cost for integrated H2O2 plants by a third to a half, relative to conventional technology (see Focus on Catalysts, Dec 2004, 6, and the patent abstract below). Chemical and Engineering News, 14 Mar 2005, 83 (11), 14-15 (Website: http://www.cen-online.org) & European Chemical News, 21 Mar 2005, 82 (2139), 29 & Chemical Week, 16 Mar 2005, 167 (9) (Website: http://www.chemweek.com) & Chemische Rundschau, 22 Mar 2005, (3), 16 (in German) & Chimie Pharma Hebdo, 14 Mar 2005, (291), 12 (in French) & Press release from: Degussa AG. Website: http://www.degussa.de (9 Mar 2005)
Headwaters’ nanocatalyst improves reforming Headwaters Inc announced that its wholly owned subsidiary, Headwaters
5
VioQuest Pharmaceuticals expands commercial catalyst portfolio VioQuest Pharmaceuticals Inc is pleased to announce that subsidiary Chiral Quest has introduced its proprietary chiral catalyst DuanPhos for commercial-scale shipping on a kilogram scale. VioQuest, in addition to acquiring innovative oncologic, metabolic, and anti-inflammatory therapeutic compounds for unmet medical needs, offers a growing family of latest generation technology in the manufacture of optically pure therapeutics for the pharmaceutical industry. VioQuest Pharmaceuticals Inc is a drug development company focused on acquiring and bringing to market therapies for oncology, metabolic, and inflammatory diseases and disorders that are current unmet medical needs. Press release from: VioQuest Pharmaceuticals Inc, 149 West Fairmount Avenue, State College, PA 16801, USA. Tel: +1 814 234 2348. Fax: +1 814 234 2494. E-mail: [email protected]. Website: http://www.chiralquest.com (4 Apr 2005)
NEW PLANTS Criterion to re-open hydroprocessing catalyst plant Criterion Catalysts and Technologies is to re-open a mothballed hydroprocessing catalyst plant in Michigan City, IN. The market for these catalysts is growing by 45%/year, partly because of the growing need for catalysts to make low-sulfur diesel fuel.
ON
C ATA LY S T S
manufacture speciality catalysts and pharmaceutical actives ingredients and intermediates. The company’s medium term plans are for sales of Yen 10.5 bn and an ordinary profit of Yen 790 M. In the year to Mar 2005 sales will rise 3.9% to Yen 9.6 bn and ordinary profit will be unchanged at Yen 590 M. Japan Chemical Week, 31 Mar 2005, 46 (2312), 6
Petrochina planning hydrocracking unit PetroChina Co Ltd is investing $3.29 bn to expand capacity at its refining and petrochemical complex at Dushanzi, Xinjiang Province, China. It will install UOP LLC proprietary technology in a hydrocracking facility which is due onstream in 2007. The unit will process 41,000 bbl/day of gasoil to produce ethylene and diesel.
Hydrocarbon Processing, Mar 2005, 85 (3), 34
Foster Wheeler wins hydrotreater project Foster Wheeler Iberia, a wholly-owned subsidiary of Foster Wheeler, has signed a detailed engineering, equipment and material supply, and construction contract with AB Mazeikiai Nafta, for a fluid catalytic cracker gasoline selective hydrotreater unit (Axens license) at Mazeikiai refinery in northwest Lithuania. The contract value is about $43 M. The termination of the project is scheduled for 4Q 2006. The facility comprises of a 32,000 bbl/day sulfur hydrogenation unit and 22,000 bbl/day hydrodesulfurisation unit. Chemical Engineering World, Feb 2005, 40 (2), 55
Oil and Gas Journal, 14 Mar 2005, 103 (10), 10
Qatar Petroleum, Sasol Chevron sign MOU for GTL base oil project Qatar Petroleum and Sasol Chevron announce the signing of a Memorandum of Understanding for GTL Base Oils. The Memorandum of Understanding defines how the two parties intend to design, construct, and operate a Base Oils plant in Qatar as a value-add retrofit to ORYX GTL. Expected start-up is the 1H of 2008. ORYX GTL, a jv between Qatar Petroleum and Sasol, is a world first and is the largest commercial GTL plant outside South Africa. The new Base Oils plant will produce a range of high quality base oils. GTL base oils are the primary feedstock for high quality lubricants. The technology for the Base Oils project will be supplied by Chevron Texaco.
Chemical Week, 16 Mar 2005, 167 (9), 6 & European Chemical News, 21 Mar 2005, 82 (2139), 12
Press release from: Sasol, USA. Website: http://www.sasol.com (2 Mar 2005) & European Chemical News, 4 Apr 2005, 82 (2141), 23 & Chimie Pharma Hebdo, 14 Mar 2005, (291), 11 (in French)
Yuki Gosei to construct Grignard reaction plant
Haldor provides licencing and engineering to an ammonia plant
Yuki Gosei Kogyo is to invest Yen 3 bn to expand its plant at Tokwa, Japan, in a project that will, take from Apr 2005 to Apr 2007. The expansion includes a continuous Grignard reaction plant and units to
Haldor Topsoe A/S will provide licensing, engineering design, catalyst, and critical equipment supply to Ningxia Petrochemical Co’s ammonia plant revamp in the Ningxia Hui Autonomous Region. Ammonia
MAY 2005
capacity will be raised from 907,000 tonne/day to 1.5 M tonne/day. Topsoe will utilise its prereforming technology.
NEW TECHNOLOGY Peroxide-PO processes integrated DegussaHeadwaters, a jv of Degussa and the technology company Headwaters, has successfully integrated its pilot plant for synthesizing hydrogen peroxide directly from hydrogen and oxygen with a pilot plant for producing propylene oxide from hydrogen peroxide. DegussaHeadwaters expects to make the route commercially available in 2007. The companies believe they can reduce the investment cost for integrated H2O2 plants by a third to a half, relative to conventional technology (see Focus on Catalysts, Dec 2004, 6, and the patent abstract below). Chemical and Engineering News, 14 Mar 2005, 83 (11), 14-15 (Website: http://www.cen-online.org) & European Chemical News, 21 Mar 2005, 82 (2139), 29 & Chemical Week, 16 Mar 2005, 167 (9) (Website: http://www.chemweek.com) & Chemische Rundschau, 22 Mar 2005, (3), 16 (in German) & Chimie Pharma Hebdo, 14 Mar 2005, (291), 12 (in French) & Press release from: Degussa AG. Website: http://www.degussa.de (9 Mar 2005)
Headwaters’ nanocatalyst improves reforming Headwaters Inc announced that its wholly owned subsidiary, Headwaters
5